New TB vaccines are on the horizon, but their success is not guaranteed. World leaders pledged to deliver at least USD $2 billion annually for TB research, including vaccines, at the 2018 United Nations High-Level Meeting (UNHLM) to End TB. Despite these commitments, TB research is impeded by an annual US$1.1 billion shortfall, while funding for TB vaccines has never exceeded US$120 million per year. These commitments cannot be in vain. We need to make up for lost time.
The TB Vaccine Advocacy Roadmap (TB Vax ARM) represents a global coalition of TB stakeholders, including TB survivors, civil society organizations, and scientific non-profits, invested in TB vaccine advocacy and research. We have come together to deliver an open letter the G20 Health and Finance Ministers, signed by TB survivors and over 50 organisations around the world, with a call for them to fulfil their commitments to fund TB vaccine research.